Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1075 of 2026 entries
View as:

A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.

Phase: N/A Priority: Normal
NCT ID: NCT00545051 Org: User:
Start: 05/31/06 End: 05/31/09 Due: 05/31/10

Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) Participants

Phase: N/A Priority: Normal
NCT ID: NCT02187627 Org: User:
Start: 08/31/14 End: 02/29/16 Due: 02/28/17

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GDC-0853 in Healthy Japanese and Caucasian Participants

Phase: N/A Priority: Normal
NCT ID: NCT03188783 Org: User:
Start: 01/24/17 End: 08/09/17 Due: 08/09/18

An Observational Quality of Life Study in Participants With Rheumatoid Arthritis Treated With Rituximab

Phase: N/A Priority: Normal
NCT ID: NCT02507752 Org: User:
Start: 07/31/09 End: 06/30/12 Due: 06/30/13

A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease

Phase: N/A Priority: Normal
NCT ID: NCT02561039 Org: User:
Start: 12/31/06 End: 03/31/08 Due: 03/31/09

A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection.

Phase: N/A Priority: Normal
NCT ID: NCT00377182 Org: User:
Start: 09/30/06 End: 08/31/08 Due: 08/31/09

A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002448 Org: User:
Start: 10/31/99 End: - Due: -

A Study Evaluating the Efficacy and Safety of Adjuvant Platinum-Doublet Chemotherapy, With or Without Atezolizumab, in Patients Who Are ctDNA Positive After Complete Surgical Resection of Stage IB to Select IIIB Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04611776 Org: User:
Start: 07/01/21 End: 01/08/26 Due: 01/08/27

A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS)

Phase: N/A Priority: Normal
NCT ID: NCT02024789 Org: User:
Start: 05/05/14 End: 05/04/16 Due: 05/04/17

An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01951170 Org: User:
Start: 11/30/13 End: 08/31/15 Due: 08/31/16

A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02767765 Org: User:
Start: 06/30/03 End: 10/31/06 Due: 10/31/07

A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.

Phase: N/A Priority: Normal
NCT ID: NCT01088659 Org: User:
Start: 02/16/10 End: 12/29/17 Due: 12/29/18

Placebo-Controlled, Single and Multiple Ascending Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986089 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02145234 Org: User:
Start: 06/30/14 End: 02/29/16 Due: 02/28/17

A Cross-over Study Examining the Bioequivalence of 3 Test Formulations to a Reference Formulation of Alectinib (RO5424802) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02074553 Org: User:
Start: 02/28/14 End: 09/30/14 Due: 09/30/15

An Extension Study of WA19926 of the Long-Term Safety of Tocilizumab (RoActemra/Actemra) in Patients With Early Moderate to Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01664598 Org: User:
Start: 05/31/12 End: 06/30/15 Due: 06/30/16

A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00118755 Org: User:
Start: 07/31/05 End: - Due: -

A Pharmacodynamic and Pharmacokinetic Study of RO4917838 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01543529 Org: User:
Start: 02/28/12 End: 06/04/12 Due: 06/04/13

A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00823680 Org: User:
Start: 04/30/09 End: 08/31/09 Due: 08/31/10

ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)?

Phase: N/A Priority: Normal
NCT ID: NCT01460446 Org: User:
Start: 10/31/11 End: 09/30/12 Due: 09/30/13

An Observational Study of Tarceva (Erlotinib) in Participants With Locally Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer (ELEMENT)

Phase: N/A Priority: Normal
NCT ID: NCT01836133 Org: User:
Start: 05/31/13 End: 01/31/16 Due: 01/31/17

Safety of Xeloda in Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02479217 Org: User:
Start: 07/31/06 End: 06/30/09 Due: 06/30/10

A Study of PEGASYS (Peginterferon Alfa-2a [40KD]) in Patients With Hepatitis B e Antigen (HBeAg)-Negative Chronic Hepatitis B Virus (HBV)

Phase: N/A Priority: Normal
NCT ID: NCT02570191 Org: User:
Start: 11/30/04 End: 02/28/07 Due: 02/28/08

A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00642733 Org: User:
Start: 08/31/07 End: 04/30/09 Due: 04/30/10

A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1)

Phase: N/A Priority: Normal
NCT ID: NCT02951767 Org: User:
Start: 05/31/14 End: 02/28/23 Due: 02/28/24

An Observational Study of Methoxy Polyethylene Glycol-epoetin Beta in Participants With a Kidney Transplant

Phase: N/A Priority: Normal
NCT ID: NCT02538107 Org: User:
Start: 09/30/07 End: 11/30/11 Due: 11/30/12